Aging
Navigate
Correction|Volume 15, Issue 12|pp 5951—5953

Correction for: Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer

Linli Hu1, Songying Zhang2, Song Quan3, Jieqiang Lv4, Weiping Qian5, Yuanhua Huang6, Weiying Lu6, Yingpu Sun1
  • 1The First Affiliated Hospital of Zhengzhou University, Reproductive Medicine, Zhengzhou, China
  • 2Sir Run Run Shaw Hospital of Zhejiang University, Reproductive Medicine, Hangzhou, China
  • 3Southern Medical University, Reproductive Medicine, Guangzhou, China
  • 4Second Affiliated Hospital of Wenzhou Medical University, Reproductive Medicine, Wenzhou, China
  • 5Peking University Shenzhen Hospital, Reproductive Medicine, Shenzhen, China
  • 6Hainan Medical College, Reproductive Medicine, Haikou, China
Received: March 27, 2023Accepted: June 20, 2023Published: June 29, 2023

Copyright: © 2023 Hu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.